The pharmaceutical Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89% reduction in hospitalization or lethal cases in high-risk patients
COVID-19 Collection thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
LumiraDx Shares Rise 13% Premarket on EUA Submission to FDA morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Pfizer submits request to the FDA to authorize vaccine for children under 12 news12.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news12.com Daily Mail and Mail on Sunday newspapers.